A crosstalk between apoptosis and autophagy exists, and the interaction of anti-apoptotic regulators such as Bcl-2 and Bcl-xl suppresses the autophagy promoter Beclin-1 activity, resulting in autophagy inhibition (Pattingre et al., 2005)
Practical tips for patients navigating both drug classes If you are a patient who has been prescribed either Toujeo or a GLP-1 medication, or if you are trying to understand your options, these practical considerations can help
Recent work indicates that oxidative stress or mitochondrial damage can promote MAVS signaling, enhancing the expression of type I interferons and pro-inflammatory cytokines [134, 135]
However, some studies have provided strong evidence for the beneficial effects of GLP-1RA in children with type 2 diabetes mellitus (T2D) and obesity, and have paved the way for GLP-1RA to be introduced to pediatric clinical practice [Reference Tamborlane, Barrientos-Perez, Fainberg, Frimer-Larsen, Hafez and Hale3942]